RSS

Archivi categoria: diabete

Modusonline, il portale per persone con diabete e non solo

Il portale dedicato alle persone con diabete e non solo. Attualità, approfondimenti e consigli pratici e molto altro per vivere meglio con il diabete

Sorgente: Modusonline, il portale per persone con diabete e non solo

 

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis – The Lancet Diabetes & Endocrinology

SGLT2 inhibitors reduced the risk of dialysis, transplantation, or death due to kidney disease in individuals with type 2 diabetes and provided protection against acute kidney injury. These data provide substantive evidence supporting the use of SGLT2 inhibitors to prevent major kidney outcomes in people with type 2 diabetes.

Sorgente: SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis – The Lancet Diabetes & Endocrinology

 

Updates on the Management of Diabetes in Dialysis Patients

Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) in the U.S. and many countries globally. The role of improved glycemic control in ameliorating the exceedingly high mortality risk of diabetic dialysis patients is unclear. The treatment …

Sorgente: Updates on the Management of Diabetes in Dialysis Patients

 
 

HbA1c Test Significantly Underestimates Diabetes Prevalence – Renal and Urology News

Sorgente: HbA1c Test Significantly Underestimates Diabetes Prevalence – Renal and Urology News

 

Albuminuria Change and Risk of End-Stage Kidney Disease

Albuminuria change as surrogate endpoint for progression of CKD strongly supported by biological plausibility, but empirical evidence lacking.

Sorgente: Albuminuria Change and Risk of End-Stage Kidney Disease

 

SGLT2 Inhibitors: Is This the Start of a New Era?

Gregory Nichols discusses exciting new clinical trial results demonstrating the benefits of SGLT2 inhibitors, as presented at the AHA 2018 Scientific Sessions.

Sorgente: SGLT2 Inhibitors: Is This the Start of a New Era?

 
Lascia un commento

Pubblicato da su 31 dicembre 2018 in diabete, Malattie NON renali

 

Microsoft Word – Il Diabete nell’Anziano Fragile_def.doc – Il Diabete nell’Anziano Fragile_def.pdf

Sorgente: Microsoft Word – Il Diabete nell’Anziano Fragile_def.doc – Il Diabete nell’Anziano Fragile_def.pdf

 
 
%d blogger hanno fatto clic su Mi Piace per questo: